Cell Culture Vessels Market Size, Share & Trends Analysis Report By Product (Bags, Flasks, Plates, Bottles, Others), By Type (Reusable, Single Use), By End Use (Pharmaceutical & Biotechnology Companies, CMOs & CROs), By Region, And Segment Forecasts, 2024 - 2030

Cell Culture Vessels Market Size & Trends

The global cell culture vessels market size was valued at USD 3.77 billion in 2023 and is projected to witness a CAGR of 14.8% from 2024 to 2030. The rising prevalence of chronic diseases, increased investments in research and development, and a growing number of clinical trials for cell-based therapies are driving the market growth. Additionally, growing collaborations and partnerships among market players are expected to further contribute to the market growth.

The market has had a positive impact during the pandemic. This is attributed to the increased demand for research and development in diagnostics, therapeutics, and vaccine development. The urgency of these needs accelerated the adoption and innovation of cell culture technologies. The increased focus on rapid development and testing of treatments and vaccines emphasized the demand for cell culture vessels in addressing global health challenges. Thereby anticipated to significantly raise the growth of the market during the pandemic.

Furthermore, the rising incidence of chronic diseases such as cancer and diabetes significantly impacts the cell culture vessel market. This growing demand for research drives the need for specialized cell culture vessels that can support various types of cell lines and experimental conditions, ensuring accurate and reliable results. In September 2023, the Novo Nordisk Foundation invested around USD 141.29 million (€ 127 million) to build a top facility for developing and scaling cell therapies, aiming to turn research into treatments for diseases such as heart failure, Parkinson's, and cancer. Thus, the growing investment and increasing prevalence of chronic diseases is anticipated to propel the demand for cell culture vessels over the forecast period.

Moreover, the market for cell culture vessels is expected to experience significant growth in the coming years, driven by the increasing demand for personalized medicine. Advancements in personalized medicine, particularly in precision oncology, have increased the need for patient-derived cell models and cultures. Researchers are now able to use primary cells or organoids derived from patients to study disease mechanisms or test potential treatments. Thereby, the demand for cell culture vessels is predicted to grow exponentially with the increasing adoption of personalized medicine, creating significant opportunities for businesses operating in this market over the forecast period.

Market Concentration & Characteristics

The cell culture vessels industry has seen significant growth in recent years. This is attributed to factors such as steady advancements in cell culture technologies, increasing investments in biotechnology and pharmaceutical research, and a growing focus on regenerative medicine and personalized therapies. Thus, these are propelling to boost the demand for cell culture vessels market.

In the cell culture vessels industry, partnerships and collaboration activities are moderately established, with research institutions, biotech companies, and pharmaceutical firms working together to drive innovation and develop new technologies. For instance, in September 2023, Cell Culture Collective, Inc. entered into a partnership with Defined Bioscience, Inc. to distribute its serum-free stem cell culture products. Through this agreement, Cell Culture Collective will serve as an authorized distributor for Defined Bioscience's optimized animal/serum-free stem cell culture products. Thus, propelling the demand for cell culture products over the forecast period.

Regulation significantly impacts the cell culture vessels industry by ensuring product safety, quality, and efficacy, which are crucial for applications in research, drug development, and clinical settings. Additionally, evolving regulations around cell and gene therapies are pushing the industry toward more advanced and specialized cell culture solutions, shaping market dynamics and growth strategies.

The cell culture vessels industry has seen moderate growth in product expansion. This includes the development of specialized vessels designed for specific applications, such as 3D cell cultures and high-throughput screening, offering to the growing demand for more advanced and versatile cell culture solutions.

The cell culture vessels industry is experiencing a high level of regional expansion, indicating rapid growth and increasing market presence across different geographic regions. The rising demand for advanced cell culture technologies, growing investments in biotech and pharmaceutical sectors, and the establishment of new research facilities in emerging markets.

Product Insights

Based on product, the market is segmented into bags, flasks, plates, bottles, and others. The bags segment dominated the market with a share of 39.41% in 2023 and is anticipated to grow at the fastest CAGR from 2024 to 2030. This is attributed to the growing preference for flexible, single use bags in cell culture applications due to their ease of use, reduced risk of contamination, and cost-effectiveness. Bags are increasingly favored for their suitability in operating a range of applications, from research to large-scale production. For instance, in March 2024, Getinge announced the launch of a novel SUPR system, a scalable single use bioreactor for pilot and GMP manufacturing. It features larger versions of their lab-scale bioreactors, comes sterilized by gamma irradiation, and is more space-efficient. It also includes easy-to-use click-n-go bag loading. Such launches are further anticipated to boost the growth of the segment over the forecast period.

The flasks segment is expected to register significant CAGR over the forecast period. Flasks are widely used in laboratories for various applications, including cell growth, maintenance, and experimentation due to their ability to support different types of cell cultures and their compatibility with various laboratory processes. Thus, increasing R&D activities is anticipated to boost the demand for flasks over the forecast years.

Type Insights

Based on type, the market is segmented into reusable and single use. The single use segment dominated the market with a share of 70.78% in 2023 and is anticipated to grow at the fastest CAGR over the forecast period. This is attributed to the increasing adoption of single use technologies in research and production environments, which offer significant advantages such as reduced risk of contamination, lower operational costs. In August 2024, Freudenberg Medical announced the expansion of its biopharma products to include custom single use assemblies, such as Y-connector manifolds, tubing assemblies, and multi-inlet bottle caps. These would be used in labs and CGMP bioprocesses for critical fluid transfers. Thus, anticipated to boost the growth of the segment over the forecast period.

The reusable segment is expected to register a moderate CAGR over the forecast period. This is attributed to the advantages of reusable cell culture vessels, such as their durability and long-term cost efficiency, thereby making them a better option for large-scale and high-volume applications.

End Use Insights

Based on end use, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and CMOs & CROs. The pharmaceutical & biotechnology companies segment dominated the market with a share of 46.62% in 2023. This is attributed to the extensive use of cell culture vessels for drug discovery, development, and production. Moreover, the high investment in R&D, coupled with the increasing focus on advanced therapies and personalized medicine, is further driving the demand for cell culture vessels significantly.

The CMOs & CROs segment is expected to register the highest CAGR over the forecast period. The rising outsourcing of research and manufacturing by pharmaceutical and biotechnology companies is anticipated to drive segmental growth over the forecast period. Furthermore, the provision of services such as drug discovery, preclinical and clinical trials, and manufacturing of cell-based therapies is contributing to the demand for cell culture vessels by CMOs & CROs.

Regional Insights

North America accounted for the largest market share of 36.19% in 2023 for the cell culture vessel market. This significant share is driven by a combination of factors, including a robust biopharmaceutical industry, high investments in research and development, and advanced healthcare infrastructure. The region's leadership in innovation and technological advancements, along with a rising incidence of chronic diseases and a supportive regulatory environment, further fuels the demand for cell culture vessels.

U.S. Cell Culture Vessels Market Trends

The cell culture vessels market in the U.S. is expected to grow over the forecast period. In July 2023, MilliporeSigma announced an investment of USD 25 million to expand its cell culture media production in Kansas, U.S.

Europe Cell Culture Vessels Market Trends

Europe cell culture vessels market was identified as a lucrative region in this industry. This growth is driven by a robust biotechnology and pharmaceutical sector. New companies and startups are emerging, and increased collaboration among research institutions is expected to further boost the market.

The cell culture vessels market in the UK held a significant share in 2023. This is attributed to the advanced research facilities, strong pharmaceutical and biotechnology sectors, and high investment in healthcare innovation. Additionally, the increasing focus on cutting-edge cell culture technologies, extensive clinical research, and the supportive regulatory environment are further contributing to the growing market growth.

France cell culture vessels market is expected to grow significantly over the forecast period. The increasing funding for healthcare research, the expansion of clinical trials, and a growing emphasis on personalized medicine are contributing to the market's expansions.

The cell culture vessels market in Germany is anticipated to grow significantly over the forecast period. In April 2024, Merck announced an investment of over USD 333.76 million (€300 million) in a new Life Science Research Center in Germany, which will consolidate research on key technologies to accelerate the development of biopharmaceutical products. Thereby propelling the demand for cell culture vessels over the forecast period.

Asia Pacific Cell Culture Vessels Market Trends

The Asia Pacific cell culture vessels market held highest CAGR of 17.84% over the forecast period. This is attributed to several factors, including increasing investments in biotechnology & pharmaceutical research, a rise in the prevalence of chronic diseases, advancements in healthcare infrastructure, and growing demand for regenerative medicine and personalized therapies. Additionally, supportive government initiatives and an expanding base of research institutions and biopharmaceutical companies in the region are further driving market growth.

The cell culture vessels market in China is expected to grow over the forecast period. This is attributed to the increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular conditions, which is expected to elevate the demand for various drugs. Thereby, increasing the demand for cell culture vessels for research, clinical applications, and drug development, thus, propelling the market growth over the forecast period.

Japan cell culture vessels market is witnessing rapid growth over the forecast period. The presence of numerous pharmaceutical & biotechnology companies, increasing health consciousness, and a growing demand for preventive healthcare are expected to boost the demand for cell culture vessels for various research activities and clinical purposes.

MEA Cell Culture Vessels Market Trends

The MEA cell culture vessels marketis expected to grow exponentially over the forecast period due to several key factors. These include increased investments in healthcare infrastructure and research, a rise in chronic diseases, widespread use of advanced diagnostic technologies, government initiatives to improve healthcare standards, and the growth of international partnerships and collaborations.

Saudi Arabia cell culture vessels market is expected to grow over the forecast period. This growth is expected to be driven by increasing collaborations between research and academic institutions for biotechnology-related research.

The cell culture vessels market in Kuwait is anticipated to grow moderately over the forecast period. This is attributed to rising healthcare expenditure aimed at improving healthcare infrastructure services, and the adoption of new technologies.

Key Cell Culture Vessels Company Insights

The market players operating in the cell culture vessels market are adopting product approval to increase the reach of their products in the market and improve the availability of their products in diverse geographical areas, along with expansion as a strategy to enhance production/research activities. In addition, several market players are acquiring smaller players to strengthen their market position. This strategy enables companies to increase their capabilities, expand their product portfolios, and improve their competencies.

Recent Development

• In April 2024, Fujifilm Corporation, announced an investment of USD1.2 billion to expand its cell culture CDMO business and increase its investment in the Fujifilm Diosynth Biotechnologies facility in Holly Springs, North Carolina, to over USD 3.2 billion in total.

• In March 2024, Novartis announced an investment of €500 million ($556.26 million) each in its Kundl and Schaftenau sites to improve the continuous production of biopharmaceuticals from Austria and support its strategy to expand cell culture technology. Thereby, boosting the demand for cell culture vessels.

• In February 2024, Thermo Scientific launched the CultiMaxx Shelving System to enhance incubator capacity for the four most common cell culture vessels. The system, compatible with Heracell VIOS 250i and Forma Steri-Cycle i250 CO2 incubators, supports up to a 150% increase in G-Rex bioreactors, enabling scalable cell therapy production without compromising performance.

Cell Culture Vessels Market Report Scope

Global Cell Culture Vessels Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global cell culture vessels market based on product, type, end use, and region.

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Bags

  • Flasks

    • T-flasks

    • Spinner Flasks

    • Gas Permeable Membrane Flasks

    • Others

  • Plates

  • Bottles

  • Others

• Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Reusable

  • Single use

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Pharmaceutical & Biotechnology Companies

  • Academic & Research Institutes

  • CMOs & CROs

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait